Medindia

X

FDA Aprroves HIV Drug Isentress for Pediatric Use

by Dr. Trupti Shirole on  December 22, 2011 at 11:22 PM Drug News   - G J E 4
The Food and Drug Administration (FDA) approved HIV drug Isentress (raltegravir) for use among children and adolescents aged 2-18 years. This Merck & Co. drug is part of a group of antiviral drugs called integrase inhibitors that block the virus from infecting cells and reproducing.
 FDA Aprroves HIV Drug Isentress for Pediatric Use
FDA Aprroves HIV Drug Isentress for Pediatric Use
Advertisement

Isentress which was approved in 2007 for adults is a twice-a-day pill and is also available as a chewable tablet. However, only the tablet form has been approved for children aged 2-11. The most common side effects among patients include insomnia and headaches.

Advertisement
Edward Cox of the FDA's center for drug evaluation and research said, "Many young children and adolescents are living with HIV and this approval provides an important additional option for their treatment."

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All